Aliri’s New Chemical Entity (NCE) support services are designed to meet the unique challenges that arise during the development of novel compounds. We work collaboratively with your team to ensure that your NCE progresses smoothly through the development pipeline, addressing both regulatory and scientific requirements.
With our expertise in pharmacokinetics and bioanalytical testing, we provide essential data and insights required to assess the safety, efficacy, and overall viability of NCEs, including:
- Small Molecule NMEs
- Lipid Nanoparticles
- Peptides
- Large Molecule NMEs
- Oligos
- RNA Therapeutics
- Protein Therapeutics
